Which drug is best for a patient with type 2 diabetes and heart failure?

被引：1

作者：

Clawson, Rebecca ^{[1
]}

Weidman-Evans, Emily ^{[1
]}

Fort, Ashley ^{[1
]}

机构：

[1] LSUHSC Sch Allied Hlth Shreveport, Shreveport, LA USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 07期

关键词：

diabetes; heart failure; SGLT-2; inhibitors; HFrEF; thiazolidinediones; metformin; CARDIOVASCULAR OUTCOMES; METFORMIN; MELLITUS; MORTALITY; DISEASE;

D O I：

10.1097/01.JAA.0000743004.83284.cc

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure is twice as common in men with type 2 diabetes than those without it and is almost five times greater in women with diabetes. Ideally, effective treatment for one condition also will help with the other; certainly, clinicians should not prescribe a medication that will potentially worsen one of the conditions, if avoiding it is at all possible. This article reviews the effects of diabetes medications on heart failure outcomes.

引用

页码：49 / 52

页数：4

共 50 条

[41] Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure
Butler, Javed
Handelsman, Yehuda
Bakris, George
Verma, Subodh
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (04) : 604 - 617
[42] The Effects of Dapagliflozin in Patients With Heart Failure Complicated With Type 2 Diabetes: A Meta-Analysis of Placebo-Controlled Randomized Trials
Zhai, Miaobo
Du, Xin
Liu, Changmei
Xu, Huipu
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2021, 2
[43] Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
Segar, Matthew W.
Kolkailah, Ahmed A.
Frederich, Robert
Pong, Annpey
Cannon, Christopher P.
Cosentino, Francesco
Dagogo-Jack, Samuel
McGuire, Darren K.
Pratley, Richard E.
Liu, Chih-Chin
Maldonado, Mario
Liu, Jie
Cater, Nilo B.
Pandey, Ambarish
Cherney, David Z., I
DIABETES OBESITY & METABOLISM, 2022, 24 (09): : 1829 - 1839
[44] Type 2 diabetes and heart failure - how to optimize cooperation of cardiologist and diabetologist
Kubickova, Marketa
Bis, Josef
COR ET VASA, 2021, 63 (03) : 373 - 377
[45] A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus
Williams, Brent A.
Geba, Daniela
Cordova, Jeanine M.
Shetty, Sharash S.
CLINICAL CARDIOLOGY, 2020, 43 (03) : 275 - 283
[46] Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry
Becher, Peter M.
Schrage, Benedikt
Ferrannini, Giulia
Benson, Lina
Butler, Javed
Carrero, Juan Jesus
Cosentino, Francesco
Dahlstrom, Ulf
Mellbin, Linda
Rosano, Giuseppe M. C.
Sinagra, Gianfranco
Stolfo, Davide
Lund, Lars H.
Savarese, Gianluigi
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 1012 - 1022
[47] Consensus document of the management of type 2 diabetes and heart failure: Consejo Interamericano de Falla Cardiaca e Hipertension Pulmonar (CIFACAH) and Inter-American Society of Cardiology (IASC)
Romero, Alexander
Saldarriaga, Clara
Ramos, Carlos E.
Quesada, Daniel
Chazzin, Gerardo
Fernandez, Felipe N.
Pow-Chon, Freddy
Alarco, Walter
Hurtado, Pablo E.
Magana, Antonio
Gomez-Mesa, Juan E.
ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 : 14 - 26
[48] Heart failure management; a perspective from diabetes care
Itzhak, Baruch
Home, Philip
DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 176
[49] Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus A Population-Based Cohort Study
Kim, Young-Gun
Yoon, Dukyong
Park, Sooyoung
Han, Seung Jin
Kim, Dae Jung
Lee, Kwan-Woo
Park, Rae Woong
Kim, Hae Jin
CIRCULATION-HEART FAILURE, 2017, 10 (09)
[50] Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes
Fitchett, David H.
Udell, Jacob A.
Inzucchi, Silvio E.
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (01) : 43 - 53

← 1 2 3 4 5 →